What are the key components of damage control resuscitation for a trauma patient with uncontrolled hemorrhage?

Damage Control Resuscitation in Trauma with Uncontrolled Hemorrhage

Damage control resuscitation combines three simultaneous priorities: immediate hemorrhage control (surgical or endovascular), permissive hypotension (systolic BP 80-90 mmHg until bleeding stops), and balanced hemostatic resuscitation with early tranexamic acid and high-ratio blood products (FFP:pRBC at least 1:2, with platelets). 1

Immediate Hemorrhage Control

Stop the bleeding first—this is the foundation of DCR. The approach depends on injury pattern:

• Damage-control surgery should be performed immediately in patients with hemorrhagic shock, ongoing bleeding, coagulopathy, or the "lethal triad" (hypothermia, acidosis, coagulopathy). Do not attempt definitive repair initially—pack, control, and get out 1

• Pelvic fractures: Apply pelvic binder pre-hospital, then proceed to early pelvic ring stabilization. If bleeding continues despite stabilization, use temporary extra-peritoneal packing or angioembolization 1

• REBOA (resuscitative endovascular balloon occlusion of the aorta) may be considered for non-compressible torso hemorrhage when other measures fail 1

Permissive Hypotension Strategy

Target systolic BP 80-90 mmHg (MAP 50-60 mmHg) until bleeding is controlled—avoid aggressive fluid resuscitation that worsens coagulopathy and disrupts clot formation 1

Critical exception: Maintain MAP ≥80 mmHg in severe traumatic brain injury (GCS <8) 1

• Use noradrenaline if restricted volume strategy fails to maintain target pressure 1
• Use crystalloids (0.9% NaCl or balanced solutions) sparingly; avoid colloids due to adverse hemostatic effects 1
• Avoid hypotonic solutions (Ringer's lactate) in severe head trauma 1

Hemostatic Resuscitation Protocol

Tranexamic Acid - Give Immediately

Administer TXA as soon as possible, ideally en route to hospital, within 3 hours of injury: 1g loading dose over 10 minutes, followed by 1g infusion over 8 hours. Do not wait for laboratory results 1

Initial Blood Product Strategy

Two acceptable approaches for initial coagulation resuscitation 1:

1. Concentrate-based: Fibrinogen concentrate (or cryoprecipitate) + packed RBCs
2. Plasma-based: FFP:pRBC ratio of at least 1:2 (meaning 1 unit FFP for every 2 units pRBC minimum)

High platelet:pRBC ratios should also be applied 1

Target Hemoglobin

Aim for Hb 70-90 g/L once transfusion is necessary 1

Goal-Directed Coagulation Management

After initial resuscitation, use viscoelastic monitoring (TEG/ROTEM) and/or standard coagulation tests to guide further therapy 1:

Fibrinogen Replacement

• Initial dose: 3-4g fibrinogen concentrate (or 5-20 units cryoprecipitate) 1
• Repeat doses guided by viscoelastic monitoring or fibrinogen levels 1

Platelet Transfusion

• Maintain platelets >50 × 10⁹/L in ongoing bleeding 1
• Maintain platelets >100 × 10⁹/L in traumatic brain injury 1
• Initial dose: 4-8 single units or one apheresis pack 1

Calcium Management

Monitor and maintain ionized calcium in normal range—administer calcium chloride to correct hypocalcemia during massive transfusion 1

Factor Concentrates

• Use prothrombin complex concentrates (PCC) if PT/APTT >1.5× normal with viscoelastic evidence of delayed coagulation initiation and normal fibrinogen 1
• Recombinant Factor VIIa only as last resort if bleeding persists despite all other measures 1

Prevent the Lethal Triad

Temperature Management

Employ early measures to prevent heat loss and actively warm hypothermic patients to achieve normothermia 1. Hypothermia worsens coagulopathy exponentially.

Avoid Acidosis

Maintain adequate tissue perfusion with balanced resuscitation—acidosis impairs coagulation factor function.

Common Pitfalls to Avoid

• Do not delay TXA administration waiting for laboratory confirmation 1
• Do not use FFP to correct hypofibrinogenemia—use fibrinogen concentrate or cryoprecipitate instead 1
• Do not over-resuscitate with crystalloids—this dilutes clotting factors and worsens coagulopathy 1
• Do not attempt definitive surgical repair in unstable patients—pack and temporize 1
• Do not forget calcium replacement during massive transfusion—citrate in blood products chelates calcium 1

The European guideline 1 represents the most comprehensive and recent (2023) evidence-based framework for DCR, supported by multiple research studies 2, 3, 4 confirming these principles improve survival in hemorrhaging trauma patients.